Rebecca Velez Frey

Directeur/Membre du Conseil chez Siduma Therapeutics, Inc.

Health Technology

Finance

Consumer Services

Postes actifs de Rebecca Velez Frey

Sociétés	Poste	Début	Fin
Elm Street Advisors LLC Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.	Private Equity Investor	01/02/2021	-
Halda Therapeutics LLC Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT.	Directeur/Membre du Conseil	-	-
	Corporate Officer/Principal	-	-
Siduma Therapeutics, Inc. Siduma Therapeutics, Inc. BiotechnologyHealth Technology Siduma Therapeutics, Inc. develops medicines that utilize the body's innate biology.	Directeur/Membre du Conseil	01/12/2021	-
	Directeur Général	01/12/2021	-

Historique de carrière de Rebecca Velez Frey

Anciens postes connus de Rebecca Velez Frey

Sociétés	Poste	Début	Fin
Evolveimmune Therapeutics, Inc. Evolveimmune Therapeutics, Inc. BiotechnologyHealth Technology EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT.	Directeur des opérations	01/02/2020	31/12/2021
Cardurion Pharmaceuticals LLC Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA.	Directeur des opérations	01/01/2018	31/12/2020
ALEXION PHARMACEUTICALS, INC.	President	01/08/2012	30/09/2017
Novartis Inflammasome Research, Inc. Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Novartis Inflammasome Research, Inc. operates as a biopharmaceutical company, which engages in the development of a suite of NOD-, LRR- and pyrin domain-containing 3 (NLRP3) antagonists for the treatment of inflammatory diseases. It also develops chemically distinct systemic, gut-directed, and central nervous system (CNS)-penetrant drug candidates to address a breadth of indications triggered by NLRP3, including metabolic, fibrotic, autoimmune, autoinflammatory, and neurological diseases. The company was founded by Eicke Latz and Luigi Franchi in 2017 and is headquartered in Boston, MA.	Directeur/Membre du Conseil	01/07/2002	30/09/2006

Formation de Rebecca Velez Frey

Northeastern University

Undergraduate Degree

Statistiques

Internationale

Etats-Unis

Opérationnelle

Director/Board Member	3
Chief Operating Officer	2
Private Equity Investor	1

Sectorielle

Health Technology	6
Finance	2
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Entreprise privées	7
Elm Street Advisors LLC Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.	Finance
Halda Therapeutics LLC Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT.	Health Services
Evolveimmune Therapeutics, Inc. Evolveimmune Therapeutics, Inc. BiotechnologyHealth Technology EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT.	Health Technology
Novartis Inflammasome Research, Inc. Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Novartis Inflammasome Research, Inc. operates as a biopharmaceutical company, which engages in the development of a suite of NOD-, LRR- and pyrin domain-containing 3 (NLRP3) antagonists for the treatment of inflammatory diseases. It also develops chemically distinct systemic, gut-directed, and central nervous system (CNS)-penetrant drug candidates to address a breadth of indications triggered by NLRP3, including metabolic, fibrotic, autoimmune, autoinflammatory, and neurological diseases. The company was founded by Eicke Latz and Luigi Franchi in 2017 and is headquartered in Boston, MA.	Health Technology
Cardurion Pharmaceuticals LLC Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA.	Health Technology
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology
Siduma Therapeutics, Inc. Siduma Therapeutics, Inc. BiotechnologyHealth Technology Siduma Therapeutics, Inc. develops medicines that utilize the body's innate biology.	Health Technology

Voir les connexions sociétés